Inhibition of p53 resulted in a modest improvement in survival, indicating that p53 may not be a driver of neurodegeneration, an observation supported by rodent ALS models (Kuntz et al., 2000). This evidence concerns the gene TP53 and amyotrophic lateral sclerosis.